Minimally verbal autistic preschoolers gained new words and phrases in a head-to-head comparison of two interventions.

In this episode of “Synaptic,” Kasari talks about the need for inclusion in educating autistic children, what drew her into the autism research field, and growing up on the family farm.

Changes to the DSM-5’s diagnostic criteria for autism were meant to add clarity, but they also generated new questions.

A careful clinician who prizes evidence, Jeremy Veenstra-VanderWeele is happy to embrace trial failures, as long as he learns from them.

This month’s issue of Going on Trial takes a sneak peek at some early null results from a small trial of a cannabidiol-based drug for autism, among other recent drug developments.

A potential threat to the integrity of data collected online and an analysis of the structure and function of dopamine receptors caught researchers’ attention on social media this week.

Here is a roundup of news and research for the week of 22 May.

Autistic people tend to drop out of Medicaid once they reach adulthood in states that don’t waive the income restrictions on enrollment.

The drug clemastine and other compounds that fortify the protective sheath around neurons may prove therapeutic for some genetic neurodevelopmental conditions.

These scores — composite measures of a person’s autism-linked common genetic variants — cannot predict an autism diagnosis but could help researchers better understand the condition’s underlying biology.